JP Morgan Downgrades bluebird bio to Neutral
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Eric Joseph has downgraded bluebird bio (NASDAQ:BLUE) from Overweight to Neutral.
August 15, 2024 | 10:54 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
JP Morgan analyst Eric Joseph downgraded bluebird bio from Overweight to Neutral, indicating a less optimistic outlook on the stock.
A downgrade from a major financial institution like JP Morgan typically signals a less favorable view on the stock, which can lead to a decrease in investor confidence and a potential short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100